Christopher S. Henney, Director at Prothena Corp plc (PRTA), sold 5,000 shares at $75.00 ($375K) on 2015-11-27, disclosed to the SEC on 2015-12-01.
Scheduled sale ($375k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PRTA | SELL | 2021-06-29 | $1.1M | — | Filing → |
| PRTA | SELL | 2017-09-29 | $63K | — | Filing → |
| PRTA | SELL | 2017-07-19 | $331K | — | Filing → |